Literature DB >> 26413885

A Single Dose of Intraoperative Antibiotics Is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy.

Ben H Chew1, Ryan Flannigan1, Michael Kurtz2, Boris Gershman2, Olga Arsovska1, Ryan F Paterson1, Brian H Eisner2, Dirk Lange1.   

Abstract

BACKGROUND: American Urology Association (AUA) Best Practice Guidelines for ureteroscopic stone treatment recommend antibiotic coverage for <24 hours following the procedure. The purpose of this study was to evaluate if the addition of postoperative antibiotics reduces urinary tract infections (UTIs) following ureteroscopic stone treatment beyond the recommended preoperative dose.
METHODS: A retrospective review was performed of consecutive patients at two institutions, University of British Columbia and Massachusetts General Hospital, Harvard. All patients received a single dose of antibiotics before ureteroscopic stone treatment. A subset of patients was also given postoperative antibiotics. The rate of UTI was compared in patients receiving only preoperative antibiotics (group 1) vs those who received pre- and postoperative antibiotics (group 2).
RESULTS: Eighty-one patients underwent ureteroscopy for renal calculi. Mean time to follow up was 42 ± 88 days. Eight (9.9%) patients in total (two from group 1 and six from group 2, p = 0.1457) developed UTIs postoperatively. In group 1, both patients presented with pyelonephritis (n = 2); those patients with infections in group 2 presented with urosepsis (n = 2) and cystitis (n = 2) and two patients had asymptomatic bacteriuria. Risk factors such as preoperative stenting, nephrostomy tubes, and foley catheters neither differed between groups nor did they predispose patients to postoperative infections.
CONCLUSIONS: The postoperative UTI rate in this study (9.9%) is consistent with previous reports. Our data suggest that a single preoperative dose of antibiotics is sufficient, and additional postoperative antibiotics do not decrease infection rates after ureteroscopic stone treatment. Risk for selection bias is a potential limitation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26413885     DOI: 10.1089/end.2015.0511

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

Review 1.  Antibiotic use and the prevention and management of infectious complications in stone disease.

Authors:  Daniel A Wollin; Adrian D Joyce; Mantu Gupta; Michael Y C Wong; Pilar Laguna; Stavros Gravas; Jorge Gutierrez; Luigi Cormio; Kunjie Wang; Glenn M Preminger
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

2.  Does the use of ureteral stents with extraction strings increase urinary infection rates?

Authors:  Yuval Freifeld; Demitry Goldin; Luai Khalili; Boris Friedman; Leonid Boyarsky; Ilan Klein; Faris Gazy; Avi Stein; Yoram Dekel
Journal:  Int Urol Nephrol       Date:  2017-02-09       Impact factor: 2.370

3.  Trends of percutaneous nephrolithotomy in Saudi Arabia.

Authors:  Wissam Khalid Kamal; Ali Alhazmy; Majed Alharthi; Aiman Al Solumany
Journal:  Urol Ann       Date:  2020-10-15

4.  Risk factors for urinary infection after retrograde upper urinary lithotripsy: Implication for nursing.

Authors:  Chuan Peng; Zhaozhao Chen; Jun Xu
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

5.  A Novel Nomogram for Predicting Post-Operative Sepsis for Patients With Solitary, Unilateral and Proximal Ureteral Stones After Treatment Using Percutaneous Nephrolithotomy or Flexible Ureteroscopy.

Authors:  Jian-Xuan Sun; Jin-Zhou Xu; Chen-Qian Liu; Yang Xun; Jun-Lin Lu; Meng-Yao Xu; Ye An; Jia Hu; Cong Li; Qi-Dong Xia; Shao-Gang Wang
Journal:  Front Surg       Date:  2022-04-15

Review 6.  Prevention and management of urosepsis triggered by ureteroscopy.

Authors:  Kymora B Scotland; Dirk Lange
Journal:  Res Rep Urol       Date:  2018-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.